Evidence map›Paper›PMID 34100034›Full record

ReviewChemical Society reviews2021

Atomically precise graphene nanoribbons: interplay of structural and electronic properties.

R S Koen Houtsma, Joris de la Rie, Meike Stöhr

Abstract readReview
In one paragraph

Review in Chemical Society reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Ultra-narrow donor-acceptor nanoribbons.Nature communications · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Highly Structure-Selective On-Surface Synthesis of Isokekulene Versus Kekulene.Angewandte Chemie (International ed. in English) · 2025
    Article
  11. Article
  12. Highly Ordered Single DomainThe journal of physical chemistry. C, Nanomaterials and interfaces · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

R S Koen HoutsmaZernike Institute for Advanced Materials, University of Groningen, Nijenborgh 4, 9747AG, Groningen, The Netherlands. r.s.k.houtsma@rug.nl m.a.stohr@rug.nl.
Joris de la Rie
Meike Stöhr

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene nanoribbons hold great promise for future applications in nanoelectronic devices, as they may combine the excellent electronic properties of graphene with the opening of an electronic band gap - not present in graphene but required for transistor applications. With a two-step on-surface synthesis process, graphene nanoribbons can be fabricated with atomic precision, allowing precise control over width and edge structure. Meanwhile, a decade of research has resulted in a plethora of graphene nanoribbons having various structural and electronic properties. This article reviews not only the on-surface synthesis of atomically precise graphene nanoribbons but also how their electronic properties are ultimately linked to their structure. Current knowledge and considerations with respect to precursor design, which eventually determines the final (electronic) structure, are summarized. Special attention is dedicated to the electronic properties of graphene nanoribbons, also in dependence on their width and edge structure. It is exactly this possibility of precisely changing their properties by fine-tuning the precursor design - offering tunability over a wide range - which has generated this vast research interest, also in view of future applications. Thus, selected device prototypes are presented as well.

Identifiers

PMID34100034
PMCPMC8185524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.